Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Hang, Peng-zhou"" wg kryterium: Autor


Wyświetlanie 1-19 z 19
Tytuł :
Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway.
Autorzy :
Liu, Guang ‐ zhong
Hou, Ting ‐ ting
Yuan, Yue
Hang, Pengzhou
Zhao, Jing ‐ jing
Sun, Li
Zhao, Guan ‐ qi
Zhao, Jing
Dong, Jing ‐ mei
Wang, Xiao ‐ bing
Shi, Hang
Liu, Yong ‐ wu
Zhou, Jing ‐ hua
Dong, Zeng ‐ xiang
Liu, Yang
Zhan, Cheng ‐ chuang
Li, Yue
Li, Wei ‐ min
Liu, Guang-Zhong
Hou, Ting-Ting
Pokaż więcej
Temat :
FENOFIBRATE
TISSUE remodeling
ATRIAL fibrillation
SIRTUINS
ELECTROPHYSIOLOGY
Źródło :
British Journal of Pharmacology; Mar2016, Vol. 173 Issue 6, p1095-1109, 15p, 4 Charts, 8 Graphs
Czasopismo naukowe
Tytuł :
Letter by Hang and Zhao Regarding Article, "Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure".
Autorzy :
Hang PZ; Department of Pharmacy (P.-z.H.), Clinical Medical College, Yangzhou University; Northern Jiangsu People's Hospital, Yangzhou, China.
Zhao J; Medical Research Center (J.Z.), Clinical Medical College, Yangzhou University; Northern Jiangsu People's Hospital, Yangzhou, China.
Pokaż więcej
Źródło :
Circulation [Circulation] 2021 Jan 26; Vol. 143 (4), pp. e24-e25. Date of Electronic Publication: 2021 Jan 25.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Brain-derived neurotrophic factor mimetic, 7,8-dihydroxyflavone, protects against myocardial ischemia by rebalancing optic atrophy 1 processing.
Autorzy :
Wang Z; Institute of Clinical Pharmacology, The Second Affiliated Hospital (The University Key Laboratory of Drug Research, Heilongjiang Province), Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, 150086, China.
Wang SP; Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
Shao Q; Department of Cardiology, The Third Affiliated Hospital of Harbin Medical University, Harbin, 150081, China.
Li PF; Institute of Clinical Pharmacology, The Second Affiliated Hospital (The University Key Laboratory of Drug Research, Heilongjiang Province), Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, 150086, China.
Sun Y; Institute of Clinical Pharmacology, The Second Affiliated Hospital (The University Key Laboratory of Drug Research, Heilongjiang Province), Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, 150086, China.
Luo LZ; Institute of Clinical Pharmacology, The Second Affiliated Hospital (The University Key Laboratory of Drug Research, Heilongjiang Province), Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, 150086, China.
Yan XQ; Institute of Clinical Pharmacology, The Second Affiliated Hospital (The University Key Laboratory of Drug Research, Heilongjiang Province), Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, 150086, China.
Fan ZY; Institute of Clinical Pharmacology, The Second Affiliated Hospital (The University Key Laboratory of Drug Research, Heilongjiang Province), Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, 150086, China.
Hu J; Institute of Clinical Pharmacology, The Second Affiliated Hospital (The University Key Laboratory of Drug Research, Heilongjiang Province), Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, 150086, China.
Zhao J; Department of Cardiology, The First Affiliated Hospital of Harbin Medical University (Key Laboratory of Cardiac Diseases and Heart Failure, Harbin Medical University), Harbin, 150001, China. Electronic address: .
Hang PZ; Institute of Clinical Pharmacology, The Second Affiliated Hospital (The University Key Laboratory of Drug Research, Heilongjiang Province), Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, 150086, China. Electronic address: .
Du ZM; Institute of Clinical Pharmacology, The Second Affiliated Hospital (The University Key Laboratory of Drug Research, Heilongjiang Province), Department of Clinical Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, 150086, China; State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China. Electronic address: .
Pokaż więcej
Źródło :
Free radical biology & medicine [Free Radic Biol Med] 2019 Dec; Vol. 145, pp. 187-197. Date of Electronic Publication: 2019 Sep 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain-Derived Neurotrophic Factor/*pharmacology
GTP Phosphohydrolases/*genetics
Membrane Glycoproteins/*genetics
Myocardial Ischemia/*drug therapy
Optic Atrophy, Autosomal Dominant/*drug therapy
Protein-Tyrosine Kinases/*genetics
Animals ; Brain-Derived Neurotrophic Factor/genetics ; Cell Death/drug effects ; Cell Survival/drug effects ; Flavones/pharmacology ; GTP Phosphohydrolases/chemistry ; Heart/drug effects ; Heart/physiopathology ; Humans ; Hydrogen Peroxide/metabolism ; Mice ; Mitochondria/drug effects ; Mitochondria/metabolism ; Mitochondrial Dynamics ; Myocardial Ischemia/genetics ; Myocardial Ischemia/pathology ; Neuroprotective Agents/pharmacology ; Optic Atrophy, Autosomal Dominant/genetics ; Optic Atrophy, Autosomal Dominant/pathology
Czasopismo naukowe
Tytuł :
Reciprocal regulation between M3 muscarinic acetylcholine receptor and protein kinase C-epsilon in ventricular myocytes during myocardial ischemia in rats.
Autorzy :
Hang PZ; Institute of Clinical Pharmacology of Second Hospital, Harbin Medical University, Key Laboratory of Heilongjiang Province, Baojian Road 157, Nangang District, Harbin, Heilongjiang Province, 150081, People's Republic of China.
Zhao J
Wang YP
Sun LH
Zhang Y
Yang LL
Zhao N
Sun ZD
Mao YY
Du ZM
Pokaż więcej
Źródło :
Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2009 Nov; Vol. 380 (5), pp. 443-50. Date of Electronic Publication: 2009 Aug 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Myocardial Ischemia/*physiopathology
Myocytes, Cardiac/*metabolism
Protein Kinase C-epsilon/*metabolism
Receptor, Muscarinic M3/*metabolism
Animals ; Blotting, Western ; Immunoprecipitation ; Male ; Phosphorylation ; Protein Transport ; Rats ; Rats, Wistar ; Signal Transduction
Czasopismo naukowe
Tytuł :
M3 muscarinic acetylcholine receptor is associated with beta-catenin in ventricular myocytes during myocardial infarction in the rat.
Autorzy :
Wang YP; Institute of Clinical Pharmacology of Second Hospital, Harbin Medical University, Harbin, PR China.
Hang PZ
Sun LH
Zhang Y
Zhao JL
Pan ZW
Ji HR
Wang LA
Bi H
Du ZM
Pokaż więcej
Źródło :
Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2009 Oct; Vol. 36 (10), pp. 995-1001. Date of Electronic Publication: 2009 Mar 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Heart Ventricles/*metabolism
Myocardial Infarction/*metabolism
Myocytes, Cardiac/*metabolism
Receptor, Muscarinic M3/*metabolism
beta Catenin/*metabolism
Animals ; Choline/pharmacology ; Heart Ventricles/pathology ; Male ; Myocardial Infarction/etiology ; Myocardial Infarction/pathology ; Myocardial Ischemia/complications ; Myocardial Ischemia/metabolism ; Myocytes, Cardiac/pathology ; Protein Binding/drug effects ; Rats ; Rats, Wistar ; Tissue Distribution
Czasopismo naukowe
    Wyświetlanie 1-19 z 19

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies